Skip to main content
main-content

Vasculitis

Epidemiology

20-11-2018 | Polymyalgia rheumatica | Article

Comorbidities in polymyalgia rheumatica: A systematic review

Partington R et al. Arthritis Res Ther 2018; 20: 258. doi: 10.1186/s13075-018-1757-y

09-07-2018 | Behçet’s disease | Article

Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: Subgroup analysis of data from the VENOST study

Uluduz D et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key153

30-05-2018 | Vasculitis | Review | Article

CNS vasculitis: An approach to differential diagnosis and management

Byram K, Hajj-Ali RA, Calabrese L. Curr Rheumatol Rep 2018; 20: 37. doi: 10.1007/s11926-018-0747-z

02-04-2018 | Immunoglobulin A vasculitis | Review | Article

IgA vasculitis: Genetics and clinical and therapeutic management

González-Gay MA et al. Curr Rheumatol Rep 2018; 20: 24. doi: 10.1007/s11926-018-0735-3

02-04-2018 | Giant cell arteritis | Review | Article

Recent advances in giant cell arteritis

Guevara M, Kollipara CS. Curr Rheumatol Rep 2018; 20: 25. doi: 10.1007/s11926-018-0737-1

21-03-2018 | Vasculitis | Review | Article

Vasculitis in Africa

Genga E, Oyoo O, Adebajo A. Curr Rheumatol Rep 2018; 20: 4. doi: 10.1007/s11926-018-0711-y

13-02-2018 | Immunoglobulin A vasculitis | Review | Article

IgA vasculitis in adults

Moran SM, Reich HN. Curr Treat Options in Rheum 2018; 4: 119–132. doi: 10.1007/s40674-018-0088-0

Behçet syndrome: a contemporary view

In this review, the authors discuss the emerging, most-recent evidence on the etiology, manifestations and epidemiology of Behçet syndrome [read more].
Nat Rev Rheumatol 2018; 14: 107–119. doi: 10.1038/nrrheum.2017.208

22-09-2017 | ANCA-associated vasculitis | News

Active CV risk management needed in ANCA-associated vasculitis

A meta-analysis has highlighted the cardiovascular risk faced by patients with vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies.

19-06-2017 | Rheumatoid arthritis | Review | Article

Rheumatoid vasculitis: A diminishing yet devastating menace

In this review, the authors provide an update on the epidemiology, pathogenesis, clinical presentation, and management of rheumatoid vasculitis, an unusual complication of long-standing rheumatoid arthritis.

Kishore S, Maher L, Majithia V. Curr Rheumatol Rep 2017;19:39. doi:10.1007/s11926-017-0667-3

05-09-2016 | Vasculitis | Article

Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA

Hospitalizations of children with IgA vasculitis were analysed, and the authors concluded that annual hospitalization rates are declining in the USA across multiple age groups.

Okubo Y et al. Clin Rheumatol 2016;35:2749. doi:10.1007/s10067-016-3402-y

15-07-2016 | Giant cell arteritis | Article

The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population

UK clinical data were obtained and prevalence of giant cell arteritis and polymyalgia rheumatic were found to be higher in women than in men and in older age groups.

Yates M et al. BMC Musculoskelet Disord 2016;17:285. doi:10.1186/s12891-016-1127-3

11-04-2016 | Giant cell arteritis | Review | Article

Update on the epidemiology and treatment of giant cell arteritis

The authors discuss the importance of early diagnosis and treatment of giant cell arteritis as well as monitoring for late-onset complications in order to mitigate long-term damage. 

Koster MJ, Warrington KJ, & Kermani TA. Curr Treat Options in Rheum 2016;2:138. doi:10.1007/s40674-016-0046-7

31-12-2015 | Vasculitis | Book Chapter | Article

Classification and epidemiology

This chapter discusses the specific classification criteria, epidemiology, and etiology of vasculitis.

Watts RA, Scott DGI, & Mukhtyar C. In: Vasculitis in Clinical Practice. Springer International Publishing AG, Cham, 2015. doi:10.1007/978-3-319-14871-7_2

image credits